| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Baroda BNP Paribas Health and Wellness Fund (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.20 |
| Equity |
98.78 |
| Trep |
1.02 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
37.23% |
| Top 10 Holdings |
59.81% |
| Top 25 Holdings |
91.84% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
74.57 |
| Healthcare |
19.52 |
| Miscellaneous |
2.91 |
| Cash |
1.22 |
| Retail |
0.93 |
| Software & Services |
0.85 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
7.16 |
| PE Ratio |
45.73 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Ltd. |
9.01 |
| Divis Laboratories Ltd. |
8.01 |
| Torrent Pharmaceuticals Ltd. |
7.99 |
| Ipca Laboratories Ltd. |
6.23 |
| Lupin Ltd |
5.99 |
| Laurus Labs Limited |
5.66 |
| Apollo Hospitals Enterprises Ltd. |
5.44 |
| Fortis Healthcare Ltd |
4.50 |
| AstraZeneca Pharma India Ltd. |
3.56 |
| Glenmark Pharmaceuticals ltd |
3.42 |
| Dr. Lal Pathlabs Limited |
3.24 |
| Mankind Pharma Limited |
3.10 |
| Aurobindo Pharma Ltd. |
3.05 |
| Max Financial Services Limited |
2.43 |
| Emcure Pharmaceuticals Limited |
2.38 |
| Abbott India Ltd. |
2.29 |
| ACUTAAS CHEMICALS LIMITED |
2.24 |
| Aster DM Healthcare Limited |
2.23 |
| Zydus Lifesciences Limited |
2.15 |
| Concord Biotech Limited |
2.14 |
| Metropolis Healthcare Limited |
1.49 |
| Ajanta Pharma Ltd. |
1.49 |
| Nephrocare Health Services Limited |
1.35 |
| Manipal Health Enterprises Limited |
1.27 |
| Symbiotec Pharmalab Limited |
1.18 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|